Goat anti-DRD5 Antibody |
| Principle Name | DRD5 |
| Official Symbol | DRD5 |
| All Name and Symbols | DRD5; dopamine receptor D5 ; DBDR; DRD1B; DRD1L2; MGC10601 ; D1beta dopamine receptor; dopamine receptor D1B |
| Accession Number(s) | NP_000789.1 |
| Peptide Sequence | NREVDNDEEEGPFD, is from internal region |
| Human Gene ID(s) | 1816 |
| Non-Human GeneID(s) | |
| Important Comments | |
| Purification | Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Supplied As | lyophilized powder of 50ug or 100ug IgG; Reconsititute IgG with 100ul or 200ul sterile DI Water and final product will be formulated as 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20°C. Minimize freezing and thawing. |
| Applications | Pep ELISA |
| Tested Species | |
| Peptide ELISA | antibody detection limit dilution 1 to 128000. |
| Western Blot | Preliminary experiments gave an approx 75-80kDa band in lysates of Human Brain (hippocampus), Kidney, Spleen and Thymus after 0.1µg/ml antibody staining. Please note that currently we cannot find an explanation in the literature for the ban |
| Reference(s) | Daly G, Hawi Z, Fitzgerald M, Gill M. Mapping susceptibility loci in attention deficit hyperactivity disorder |
